✦ LIBER ✦

Low-dose gemcitabine plus cisplatin in previously treated, relapsed non-Hodgkin's lymphoma

✍ Scribed by Siu-Fun Wong; Tiberio Lindgren; Donald Hsu; George Tran

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 263 KB
Volume: 73
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.10349

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose cytosine arabinoside in previo

High-dose cytosine arabinoside in previously treated patients with poor-prognosis non-Hodgkin's lymphoma

✍ David J. Adelstein; Hillard M. Lazarus; John D. Hines; Roger H. Herzig 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB 👁 1 views

Stable low IgG levels in relapsed non-Ho

Stable low IgG levels in relapsed non-Hodgkin’s lymphomas

✍ Gabriele Buda; Sara Galimberti; Enrico Orciuolo; Francesco Caracciolo; Nadia Cec 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 95 KB

Depressed cytotoxic T-cell responses in

Depressed cytotoxic T-cell responses in previously treated Hodgkin's and non-Hodgkin's lymphoma patients

✍ Joyce M. Zarling; Cara Berman; Peter C. Raich 📂 Article 📅 1980 🏛 Springer-Verlag 🌐 English ⚖ 705 KB

Intermediate dose gemcitabine–cisplatin

Intermediate dose gemcitabine–cisplatin combination chemotherapy without treatment delay for cytopenia followed by autografting—a new standard of care in relapsed or refractory Hodgkin lymphoma?

✍ T. Todd; S. Raj; D. Camilleri; G. Stafford; R. Bulusu; G. Follows; M. Williams; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 127 KB

High-dose cytosine arabinoside in relaps

High-dose cytosine arabinoside in relapsed and refractory non-Hodgkin's lymphoma. Limited role as a single agent

✍ Robert J. Soiffer; Michael A. Caligiuri; Carlo Tondini; George P. Canellos 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

Cladribine in the treatment of advanced

Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma

✍ Anil Tulpule; Gary Schiller; Laura A. Harvey-Buchanan; Myung Lee; Byron M. Espin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## BACKGROUND. Cladribine (2-chlorodeoxyadenosine) is a purine nucleoside analog with cytotoxic activity against both resting and proliferating cells. Clinical studies with cladribine have reported antitumor activity against various hematologic malignancies.